CerSci Therapeutics

Acadia's prized pain drug from $52M buyout flops its first test
Endpoints
Tue, 04/19/22 - 10:57 am
Acadia Pharmaceuticals
CerSci Therapeutics
M&A
ACP-044
non-opioid pain treatments
Acadia Pharma Acquires CerSci, Potential Pain Meds in $52.5M Buyout
Xconomy
Wed, 08/26/20 - 10:56 am
Acadia Pharmaceuticals
M&A
CerSci Therapeutics
post-surgical pain
nerve pain